Mineralys Therapeutics, Inc. MLYS Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Mineralys Therapeutics, Inc. (MLYS) reported deferred tax assets and other non-current assets of $360K in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Mineralys Therapeutics, Inc.'s deferred tax assets and other non-current assets decreased by 9.3% year-over-year, from $397K to $360K.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s deferred tax assets and other non-current assets?
- Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s deferred tax assets and other non-current assets has grown at a 160.1% compound annual growth rate (CAGR), from $183K to $3.22M.